Ja-Ryong Koo

Ja-Ryong Koo

Auto-generated profile, based on publicly available information

Ja-Ryong Koo

Division of Nephrology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2004 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
RSRam K. Sindhu
Ram K. Sindhu
JKJa‐Ryung Koo
Ja‐Ryung Koo
CRChristian K. Roberts
Christian K. Roberts
NVNosratola D. Vaziri
Nosratola D. Vaziri
Recent evidence suggests that impaired antioxidant status is involved in oxidative stress associated with diabetes. The main antioxidant enzymes include superoxide dismutase (SOD), catalase (CAT) a...

1 May 2003 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
JKJa-Ryong Koo
Ja-Ryong Koo
JYJong-Woo Yoon
Jong-Woo Yoon
SKSeong-Gyun Kim
Seong-Gyun Kim
YLYoung-Ki Lee
Young-Ki Lee
KOKook-Hwan Oh
Kook-Hwan Oh
BSBong-Ki Son
Bong-Ki Son

1 January 2005 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
JKJa-Ryong Koo
Ja-Ryong Koo
JYJong-Yoo Yoon
Jong-Yoo Yoon
MJMin-Ha Joo
Min-Ha Joo
HLHyung-Seok Lee
Hyung-Seok Lee
JOJi-Eun Oh
Ji-Eun Oh
BSBong-Ki Son
Bong-Ki Son

1 January 2002 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
JKJa-Ryong Koo
Ja-Ryong Koo
JKJin-Cheol Kim
Jin-Cheol Kim
JYJong-Woo Yoon
Jong-Woo Yoon
Gheun-Ho KimGheun-Ho Kim
Gheun-Ho Kim
RJRho-Won Jeon
Rho-Won Jeon
JNJung-Woo Noh
Jung-Woo Noh

1 January 2003 in Kidney International
Verified
Journal Article
Closed access
JKJa-Ryong Koo
Ja-Ryong Koo
NVNosratola D. Vaziri
Nosratola D. Vaziri

18 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EKEun-Jung Kim
Eun-Jung Kim
MCMyung-Jin Choi
Myung-Jin Choi
JLJeong Hwan Lee
Jeong Hwan Lee
JOJi-Eun Oh
Ji-Eun Oh
JSJang-Won Seo
Jang-Won Seo
JKJa-Ryong Koo
Ja-Ryong Koo
In hemodialysis patients, fluid overload and malnutrition are accompanied by extracellular fluid (ECF) expansion and intracellular fluid (ICF) depletion, respectively. We investigated the relationship between ECF/ICF ratio (as an integrated marker reflecting both fluid overload and malnutrition) and survival and cardiovascular disease (CVD) in the context of malnutrition-inflammation-arteriosclerosis (MIA) complex. Seventy-seven patients from a single hemodialysis unit were prospectively enrolled. The ECF/ICF volume was measured by segmental multi-frequency bioimpedance analysis. MIA and volume status were measured by serum albumin, C-reactive protein (CRP), pulse wave velocity (PWV) and plasma B-type natriuretic peptide (BNP), respectively. The mean ECF/ICF ratio was 0.56±0.06 and the cut-off value for maximum discrimination of survival was 0.57. Compared with the low ECF/ICF group, the high ECF/ICF group (ratio≥0.57, 42%) had higher all-cause mortality, CVD, CRP, PWV, and BNP, but lower serum albumin. During the 5-year follow-up, 24 all-cause mortality and 38 CVD occurred (18 and 24, respectively, in the high ECF/ICF group versus 6 and 14 respectively in the low ECF/ICF group, P<0.001). In the adjusted Cox analysis, the ECF/ICF ratio nullifies the effects of the MIA and volume status on survival and CVD and was an independent predictor of all-cause mortality and CVD: hazard ratio (95% confidence interval); 1.12 (1.01–1.25) and 1.09 (1.01–1.18) for a 0.01 increase in the ECF/ICF ratio. The degree of malnutrition (albumin), inflammation (CRP), arteriosclerosis (PWV), and fluid overload (BNP) were correlated well with the ECF/ICF ratio. Hemodialysis patients with high ECF/ICF ratio are not only fluid overloaded, but malnourished and have stiff artery with more inflammation. The ECF/ICF ratio is highly related to the MIA complex, and is a major risk indicator for all-cause mortality and CVD.